跳至主要内容
临床试验/NCT07517887
NCT07517887已完成不适用

Anti-aging Efficacy Study on One Cosmetic Product vs Untreated

Amazentis SA1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2026年4月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Amazentis SA
入组人数
36
试验地点
1
主要终点
Skin hydration

研究概览

简要总结

The aim of this study is to investigate the impact of a topical product on skin health and aging

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Outcomes Assessor)

盲法说明

Double (Outcomes Assessor)

入排标准

年龄范围
45 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written Informed Consent to participate in the study
  • Written Informed Consent for the use of the images for marketing purposes applies to subgroup participants of study 26.
  • Willingness to actively participate in the study and to come to the scheduled visits
  • Male, approximately 10 to 15% with little facial hair
  • From 45 to 65 years of age
  • Healthy skin in the test areas
  • Visible wrinkles in the face (grade 3 to 6 according to proderm wrinkle score)

排除标准

  • Female participants: Pregnancy or lactation
  • Drug addicts, alcoholics
  • AIDS, HIV-positive or infectious hepatitis
  • Conditions which exclude a participation or might influence the test reaction/evaluation
  • Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
  • Active skin disease at the test area
  • Documented allergies to face/eye care products or their ingredients
  • Diabetes mellitus
  • Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
  • One of the following illnesses with reduced physical capability/fitness: asthma (symptom-free allergic asthma is not an exclusion criterion), hypertension (if not adjusted with medication), cardiovascular diseases
  • Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, freckles, etc. at the test area that could influence the investigation
  • Regular use of tanning beds within the last 6 weeks prior to the start of the study
  • Any topical medication at the test area within the last 3 days prior to the start of the study
  • Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) within the last 7 days prior to the start of the study and throughout the entire course of the study that in the opinion of the investigator may affect the outcome of the study
  • Therapy with antibiotics within the last 2 weeks prior to the start of the study and throughout the entire course of the study that in the opinion of the investigator may affect the outcome of the study
  • Cosmetic surgery procedure in the test area (e.g. laser, facelift) within the last 2 years and throughout the entire course of the study
  • Cosmetic surgery treatments in the test area, e.g. IPL (Intensed Pulsed Light), botox, chemical peel, dermabrasion within the last 2 years prior to the start of the study and throughout the entire course of the study
  • Medical treatment for wrinkle reduction (e.g. peeling with vitamin A or fruit acids) on the face within the last 2 weeks prior to the start of the study and throughout the entire course of the study

研究组 & 干预措施

Cosmetic routine

Experimental

The "cosmetic routine" arm will apply the skin care product

干预措施: Skin care product (Other)

Untreated control

No Intervention

The "Untreated control" arm will not apply the skin care product

结局指标

主要结局

Skin hydration

时间窗: 8 weeks

Change from baseline in skin hydration (assessed on skin capacitance by Corneometer) after 2 and 8 weeks

次要结局

  • Anti-wrinkle efficacy(8 weeks)
  • Skin barrier function(8 weeks)
  • Skin firmness(8 weeks)
  • Skin elasticity(8 weeks)
  • Clinical skin appearance(8 weeks)
  • Skin aging hallmarks(8 weeks)
  • Product traits(8 weeks)
  • Clinical Before-After Photography(8 weeks)

研究者

发起方
Amazentis SA
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Anti-aging Efficacy Study on One Cosmetic Product... | 临床试验